Key result
AI-ECG-aged status is linked to ~2-fold higher risk of incident heart failure across all EF subtypes.
Why the study?
Prior studies suggest artificial intelligence can infer biological age from the ECG, but whether AI-estimated ECG aging is associated with incident heart failure overall and across HFpEF, HFmrEF, and HFrEF subtypes needed evaluation.
Is AI-estimated ECG aging (age gap >7 years) associated with an increased risk of incident heart failure and its subtypes (HFpEF, HFmrEF, HFrEF) in individuals without a history of heart failure?
Cohort (n=285,137)
Yes
Is AI-estimated ECG aging (age gap >7 years) associated with an increased risk of incident heart failure and its subtypes (HFpEF, HFmrEF, HFrEF) in individuals without a history of heart failure?
AI-derived ECG biological aging (age gap >7 years) is consistently associated with an approximately 1.5- to 3-fold increased risk of incident heart failure across multinational cohorts and across all ejection fraction subtypes (HFpEF, HFmrEF, and HFrEF).
AI-ECG age may refine HF risk stratification; extends ECG aging prediction but leaves open prospective validation before practice change.
Background Prior studies suggest that artificial intelligence (AI) can infer “biological age” from the electrocardiogram (ECG), and that this ECG-derived aging signal may improve cardiovascular risk prediction. Purpose To evaluate whether AI-estimated ECG aging is associated with the risk of incident HF overall and with subtype-specific risks for HF with preserved (HFpEF), mildly reduced (HFmrEF), and reduced (HFrEF) ejection fraction. Methods A deep learning model was trained using 3,672,020 ECGs from 837,666 participants to estimate AI-ECG age. The model was then applied to four external cohorts from South Korea, the United Kingdom, and the United States (n=112,761; 37,734; 41,552; and 93,090), excluding individuals with a history of HF. AI-ECG-aged status was defined as an age gap (AI-ECG age minus chronological age) >7 years. Incident HF was identified from diagnoses and classified into HFpEF, HFmrEF, and HFrEF; subtype analyses were performed in one South Korean cohort. Associations were assessed using time-to-event models, with competing-risk analyses for cumulative incidence. Results During follow-up, a total of 1,528; 202; 63; and 10,328 incident HF events occurred across the four cohorts, respectively. Compared with the normal group, the AI-ECG-aged group had a consistently higher risk of incident HF in each cohort (adjusted hazard ratios [95% CI]: 2.04 [1.80–2.31], 2.11 [1.46–3.05], 2.96 [1.63–5.37], and 1.54 [1.46–1.63]). In subtype analyses, AI-ECG-aged status was associated with increased risks across all HF subtypes (HFpEF 2.46 [2.05–2.96]; HFmrEF 2.27 [1.58–3.26]; HFrEF 2.24 [1.71–2.93]), indicating broadly comparable risk amplification rather than subtype-restricted effects. In prespecified subgroup analyses, associations remained directionally consistent across key demographic and clinical strata, with no clear evidence of heterogeneity; subtype-specific risk elevations were similarly preserved across strata, suggesting that ECG aging captures a generalized HF vulnerability signal not confined to a particular EF phenotype or baseline risk profile. Conclusion AI-derived ECG aging was associated with a higher risk of incident HF across multinational cohorts and demonstrated similar magnitude risk increases across EF-defined HF subtypes. ECG-based biological aging may serve as a scalable, noninvasive marker for HF risk stratification, including subtype-oriented prediction.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2026) conducted a cohort in Incident heart failure and its subtypes (HFpEF, HFmrEF, HFrEF) (n=285,137). AI-ECG-aged status (AI-ECG age minus chronological age >7 years) vs. Normal AI-ECG age group was evaluated on Incident heart failure overall and by subtype (HFpEF, HFmrEF, HFrEF) (HR 2.04, 95% CI 1.80-2.31). AI-ECG-aged status (>7-year age gap) increased incident heart failure risk across four cohorts (aHRs 1.54 to 2.96) and all EF subtypes (HFpEF HR 2.46, HFmrEF 2.27, HFrEF 2.24).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: